AMGEN HONG KONG LIMITED

Featured products of Amgen

Amgevita

Amgevita soln for inj 40 mg/0.8 mL

adalimumab

Packing/Price

((pre-filled syringe/pen)) 2 × 1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.

Blincyto

Blincyto powd for conc & soln for soln for infusion 35 mcg

blinatumomab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Evenity

Evenity soln for inj 105 mg/1.17 mL

romosozumab

Packing/Price

2 × 1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Imdelltra

Imdelltra powd for soln for infusion 1 mg

tarlatamab

Packing/Price

1's

MIMS Class

Cancer Immunotherapy

ATC Classification

L01FX33 - tarlatamab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Imdelltra powd for soln for infusion 10 mg

tarlatamab

Packing/Price

1's

MIMS Class

Cancer Immunotherapy

ATC Classification

L01FX33 - tarlatamab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Kanjinti

Kanjinti powd & solvent for conc for soln for infusion 420 mg

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kanjinti powd for conc for soln for infusion 150 mg

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kyprolis

Kyprolis powd for soln for infusion 30 mg

carfilzomib

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.

Lumakras

Lumakras tab 120 mg

sotorasib

Packing/Price

2 × 120's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX73 - sotorasib : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Mvasi

Mvasi conc for soln for infusion 100 mg/4 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.

Neulastim

Neulastim soln for inj 6 mg/0.6 mL

pegfilgrastim

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen

Neupogen soln for inj 0.3 mg/0.5 mL

filgrastim

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen soln for inj 0.3 mg/mL

filgrastim

Packing/Price

4 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Parsabiv

Parsabiv soln for inj 2.5 mg/0.5 mL

etelcalcetide hydrochloride

Packing/Price

10 × 1's

MIMS Class

Other Agents Affecting Metabolism

ATC Classification

H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.

Parsabiv soln for inj 5 mg/mL

etelcalcetide hydrochloride

Packing/Price

10 × 1's

MIMS Class

Other Agents Affecting Metabolism

ATC Classification

H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.

Prolia

Prolia soln for inj 60 mg/mL

denosumab

Packing/Price

1 mL x 1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Repatha

Repatha soln for inj 140 mg/mL

evolocumab

Packing/Price

((autoinjector)) 1's

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.

Vectibix

Vectibix conc for soln for infusion 20 mg/mL

panitumumab

Packing/Price

5 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.

Xgeva

Xgeva soln for inj 120 mg/1.7 mL (70 mg/mL)

denosumab

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Distributed by Agencia Lei Va Hong

Blincyto

Blincyto powd for conc & soln for soln for infusion 35 mcg

blinatumomab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Evenity

Evenity soln for inj 105 mg/1.17 mL

romosozumab

Packing/Price

2 × 1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Kyprolis

Kyprolis powd for soln for infusion 30 mg

carfilzomib

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.

Neulastim

Neulastim soln for inj 6 mg/0.6 mL

pegfilgrastim

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen

Neupogen soln for inj 0.3 mg/0.5 mL

filgrastim

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen soln for inj 0.3 mg/mL

filgrastim

Packing/Price

4 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Parsabiv

Parsabiv soln for inj 2.5 mg/0.5 mL

etelcalcetide hydrochloride

Packing/Price

10 × 1's

MIMS Class

Other Agents Affecting Metabolism

ATC Classification

H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.

Parsabiv soln for inj 5 mg/mL

etelcalcetide hydrochloride

Packing/Price

10 × 1's

MIMS Class

Other Agents Affecting Metabolism

ATC Classification

H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.

Prolia

Prolia soln for inj 60 mg/mL

denosumab

Packing/Price

1 mL x 1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Repatha

Repatha soln for inj 140 mg/mL

evolocumab

Packing/Price

((autoinjector)) 1's

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.

Vectibix

Vectibix conc for soln for infusion 20 mg/mL

panitumumab

Packing/Price

5 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.

Xgeva

Xgeva soln for inj 120 mg/1.7 mL (70 mg/mL)

denosumab

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Distributed by Zuellig

Amgevita

Amgevita soln for inj 40 mg/0.8 mL

adalimumab

Packing/Price

((pre-filled syringe/pen)) 2 × 1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.

Blincyto

Blincyto powd for conc & soln for soln for infusion 35 mcg

blinatumomab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Evenity

Evenity soln for inj 105 mg/1.17 mL

romosozumab

Packing/Price

2 × 1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Imdelltra

Imdelltra powd for soln for infusion 1 mg

tarlatamab

Packing/Price

1's

MIMS Class

Cancer Immunotherapy

ATC Classification

L01FX33 - tarlatamab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Imdelltra powd for soln for infusion 10 mg

tarlatamab

Packing/Price

1's

MIMS Class

Cancer Immunotherapy

ATC Classification

L01FX33 - tarlatamab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Kanjinti

Kanjinti powd & solvent for conc for soln for infusion 420 mg

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kanjinti powd for conc for soln for infusion 150 mg

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kyprolis

Kyprolis powd for soln for infusion 30 mg

carfilzomib

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.

Lumakras

Lumakras tab 120 mg

sotorasib

Packing/Price

2 × 120's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX73 - sotorasib : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Mvasi

Mvasi conc for soln for infusion 100 mg/4 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.

Neulastim

Neulastim soln for inj 6 mg/0.6 mL

pegfilgrastim

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen

Neupogen soln for inj 0.3 mg/0.5 mL

filgrastim

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen soln for inj 0.3 mg/mL

filgrastim

Packing/Price

4 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Parsabiv

Parsabiv soln for inj 2.5 mg/0.5 mL

etelcalcetide hydrochloride

Packing/Price

10 × 1's

MIMS Class

Other Agents Affecting Metabolism

ATC Classification

H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.

Parsabiv soln for inj 5 mg/mL

etelcalcetide hydrochloride

Packing/Price

10 × 1's

MIMS Class

Other Agents Affecting Metabolism

ATC Classification

H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.

Prolia

Prolia soln for inj 60 mg/mL

denosumab

Packing/Price

1 mL x 1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Repatha

Repatha soln for inj 140 mg/mL

evolocumab

Packing/Price

((autoinjector)) 1's

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.

Vectibix

Vectibix conc for soln for infusion 20 mg/mL

panitumumab

Packing/Price

5 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.

Xgeva

Xgeva soln for inj 120 mg/1.7 mL (70 mg/mL)

denosumab

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Marketed by KLN Pharma

Neulastim

Neulastim soln for inj 6 mg/0.6 mL

pegfilgrastim

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen

Neupogen soln for inj 0.3 mg/0.5 mL

filgrastim

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen soln for inj 0.3 mg/mL

filgrastim

Packing/Price

4 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.